AR066373A1 - Formulaciones de aminoacidos n-halogenados - Google Patents
Formulaciones de aminoacidos n-halogenadosInfo
- Publication number
- AR066373A1 AR066373A1 ARP080101844A ARP080101844A AR066373A1 AR 066373 A1 AR066373 A1 AR 066373A1 AR P080101844 A ARP080101844 A AR P080101844A AR P080101844 A ARP080101844 A AR P080101844A AR 066373 A1 AR066373 A1 AR 066373A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydroxide
- transfer agent
- phase transfer
- halogenated
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/14—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-halogen bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
- A01N41/04—Sulfonic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Dentistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Método para el tratamiento de una infeccion de tejido, que comprende el contacto del tejido infectado con una cantidad farmacéuticamente eficaz de una formulacion que comprende un aminoácido N-halogenado y un agente de transferencia de fase.Formulacion que tiene actividad antimicrobiana, que comprende un aminoácido N-halogenado y un agente de transferencia de fase. Reivindicacion 2: El método de la reivindicacion 1, donde el agente de transferencia de fase se selecciona del grupo queconsiste en: aminas cuaternarias, hidroxido de tetrabutilamonio (TBAH), hidroxido de tetrapropilamonio (TPAH), cloruro de tetrabutilfosfonio (TBPC), hidroxido de hexadeciltrimetilamonio, hidroxido de dodeciltrietilamonio y sus combinaciones. Reivindicacion 4: El método de la reivindicacion 3, donde la clorotaurina es 2,2-dimetil-N,N-diclorotaurina de sodio.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91529107P | 2007-05-01 | 2007-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR066373A1 true AR066373A1 (es) | 2009-08-12 |
Family
ID=39596568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080101844A AR066373A1 (es) | 2007-05-01 | 2008-04-30 | Formulaciones de aminoacidos n-halogenados |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080275123A1 (es) |
| EP (1) | EP2139518A1 (es) |
| JP (1) | JP2010526082A (es) |
| KR (1) | KR20100017166A (es) |
| CN (1) | CN101674849A (es) |
| AR (1) | AR066373A1 (es) |
| AU (1) | AU2008245455A1 (es) |
| BR (1) | BRPI0810790A2 (es) |
| CA (1) | CA2684098A1 (es) |
| CL (1) | CL2008001279A1 (es) |
| MX (1) | MX2009011819A (es) |
| RU (1) | RU2009144292A (es) |
| TW (1) | TW200902093A (es) |
| UY (1) | UY31059A1 (es) |
| WO (1) | WO2008134687A1 (es) |
| ZA (1) | ZA200907050B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY31058A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios |
| ES2608047T3 (es) * | 2008-04-10 | 2017-04-05 | Waldemar Gottardi | Composiciones que comprenden amina N-halogenada o N,N-dihalogenada para el tratamiento y profilaxis de infecciones broncopulmonares |
| WO2009127924A1 (en) * | 2008-04-15 | 2009-10-22 | Waldemar Gottardi | Compositions and devices for antisepsis and anticoagulation |
| KR20110043661A (ko) * | 2008-08-12 | 2011-04-27 | 노바베이 파마슈티칼즈, 인코포레이티드 | 항미생물 젤 제형물 |
| US20100204181A1 (en) * | 2009-02-06 | 2010-08-12 | Alcon Research, Ltd. | N-halogenated amino acid formulations comprising phosphine or amine oxides |
| CN102625558B (zh) * | 2012-03-30 | 2014-09-03 | 安徽航天环境工程有限公司 | 带有冷却系统的等离子体加热器 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2003198C (en) * | 1988-11-29 | 1995-03-21 | Anthony J. Dziabo, Jr. | Aqueous ophthalmic solutions and method for preserving same |
| US5320805A (en) * | 1991-05-15 | 1994-06-14 | Sterilex Corporation | Methods of using a cleaner, sanitizer, disinfectant, fungicide, sporicide, chemical sterilizer |
| US5421818A (en) * | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
| US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
| US5968986A (en) * | 1997-12-18 | 1999-10-19 | Woodward Laboratories, Inc. | Antimicrobial nail coating composition |
| US6759434B2 (en) * | 1999-09-22 | 2004-07-06 | B. Ron Johnson | Anti-infective compositions, methods and systems for treating disordered tissue |
| PL1656095T3 (pl) * | 2003-08-18 | 2014-04-30 | Novabay Pharmaceuticals Inc | N,n-dwuchlorowcowane kwasy aminowe i pochodne |
| TWI386201B (zh) * | 2005-01-25 | 2013-02-21 | Novabay Pharmaceuticals Inc | Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法 |
-
2008
- 2008-04-29 UY UY31059A patent/UY31059A1/es not_active Application Discontinuation
- 2008-04-30 CN CN200880014117A patent/CN101674849A/zh active Pending
- 2008-04-30 KR KR1020097024173A patent/KR20100017166A/ko not_active Application Discontinuation
- 2008-04-30 AU AU2008245455A patent/AU2008245455A1/en not_active Abandoned
- 2008-04-30 AR ARP080101844A patent/AR066373A1/es not_active Application Discontinuation
- 2008-04-30 CA CA002684098A patent/CA2684098A1/en not_active Abandoned
- 2008-04-30 JP JP2010506582A patent/JP2010526082A/ja not_active Withdrawn
- 2008-04-30 TW TW097115865A patent/TW200902093A/zh unknown
- 2008-04-30 RU RU2009144292/15A patent/RU2009144292A/ru not_active Application Discontinuation
- 2008-04-30 EP EP08769241A patent/EP2139518A1/en not_active Withdrawn
- 2008-04-30 WO PCT/US2008/061942 patent/WO2008134687A1/en active Application Filing
- 2008-04-30 BR BRPI0810790-4A patent/BRPI0810790A2/pt not_active IP Right Cessation
- 2008-04-30 MX MX2009011819A patent/MX2009011819A/es unknown
- 2008-04-30 US US12/112,384 patent/US20080275123A1/en not_active Abandoned
- 2008-05-02 CL CL2008001279A patent/CL2008001279A1/es unknown
-
2009
- 2009-10-09 ZA ZA2009/07050A patent/ZA200907050B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200902093A (en) | 2009-01-16 |
| ZA200907050B (en) | 2010-12-29 |
| JP2010526082A (ja) | 2010-07-29 |
| RU2009144292A (ru) | 2011-06-10 |
| CA2684098A1 (en) | 2008-11-06 |
| EP2139518A1 (en) | 2010-01-06 |
| BRPI0810790A2 (pt) | 2015-06-16 |
| CN101674849A (zh) | 2010-03-17 |
| US20080275123A1 (en) | 2008-11-06 |
| MX2009011819A (es) | 2009-11-13 |
| CL2008001279A1 (es) | 2009-01-02 |
| AU2008245455A1 (en) | 2008-11-06 |
| UY31059A1 (es) | 2008-10-31 |
| WO2008134687A1 (en) | 2008-11-06 |
| KR20100017166A (ko) | 2010-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018009297A2 (pt) | composição de limpeza e desinfecção | |
| AR066373A1 (es) | Formulaciones de aminoacidos n-halogenados | |
| TW200724166A (en) | Wrinkle-improving agent | |
| EA200900959A1 (ru) | Ингибиторы мек | |
| BR112013020132A2 (pt) | lenço para uso com uma solução germicida e método para desinfetar uma superfície | |
| BRPI0414581C1 (pt) | composto, composição farmacêutica compreendendo o referido composto e uso do referido composto | |
| BRPI0412054A (pt) | preparação farmacêutica transdérmica | |
| NO20092535L (no) | Fumaratsalt av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol | |
| BRPI0908432A2 (pt) | composições antimicrobianas tópicas | |
| SA519402090B1 (ar) | مثبطات انتقائية لـ hdac6، وطريقة تحضيرها، واستخدامها | |
| BR0308133A (pt) | Forma polimórfica cristalina de cloridrato de irinotecan | |
| JOP20210338A1 (ar) | نظائر 3-(5-مثيل-3،1- ثيازول-2- يل)-n-{(1r)-1-[2-(تراي فلورومثيل) بيريميدين-5-يل] إثيل} بنزاميد | |
| MX2021007161A (es) | Agente que contiene acido ursodesoxicolico para tratar o prevenir la presbicia. | |
| CO6280474A2 (es) | Composicion farmaceutica para el tratamiento de la eyaculacion precoz | |
| BRPI0410837A (pt) | composto, composição farmacêutica, e, método para tratar ou prevenir uma doença ou condição | |
| AR081973A1 (es) | Composiciones y metodos para incrementar la reduccion de microorganismos formadores de esporas | |
| AR066372A1 (es) | Formulaciones de aminoacidos n-halogenados con compuestos antiinflamatorios | |
| CL2008001281A1 (es) | Metodo para limpiar y/o desinfectar un lente de contacto; formulacion para desinfectar un lente de contacto que comprende un amonoacido n-halogenado y un agente de transferencia de fase; composicion farmaceutica que comprende un aminoacido n-halogenado y un agente de transferencia de fase; y metodo para desinfectar o limpiar superficies | |
| PH12019502510A1 (en) | Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof | |
| CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
| FR2882522B1 (fr) | Composition pharmaceutique solide comprenant de la telithromycine | |
| CL2008001283A1 (es) | Composicion farmaceutica que comprende un acido alifatico y aminoacido n-halogenado; metodo para mejorar la actividad antimicrobiana de una formulacion; metodo para desinfectar y/o limpiar instrumentos quirurgicos o lentes de contacto, la composicion es util para tratar tejido infectado o infecciones respiratoria. | |
| PL423672A1 (pl) | Kompozycja farmaceutyczna zawierająca zebularynę oraz środek leczniczy do regeneracji ran | |
| EA201692196A1 (ru) | Применение 1,3-пропандисульфоновой кислоты или ее фармацевтически приемлемых солей для лечения саркоидоза | |
| BRPI0409441A (pt) | sal de amÈnio, composição farmacêutica, e, método para tratamento de um mamìfero sofrendo ou susceptìvel a cáncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |